Tactics of topical therapy for cutaneous vasculitis in rheumatoid arthritis


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

One of the extra-articular systemic manifestations of rheumatoid arthritis (RA) is cutaneous rheumatoid vasculitis (RV). Among the reasons for the development of RV, an important place is occupied by the deposition of immune complexes in the walls of blood vessels. This concept is based on the detection of high titers of rheumatoid factor, circulating immune complexes, as well as cryoglobulins in most RA patients with RV. Along with the use of disease-modifying anti-rheumatic drug therapy, topical treatment plays a significant role.

Texto integral

Acesso é fechado

Sobre autores

David Bestaev

North Ossetian State Medical Academy

Email: davidbestaev@rambler.ru
MD, Head of the Department of Internal Diseases № 3 Vladikavkaz, Russia

S. Ktsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

Z. Brtsieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Khutieva

North Ossetian State Medical Academy

Vladikavkaz, Russia

L. Osipova

North Ossetian State Medical Academy

Vladikavkaz, Russia

N. Burduli

North Ossetian State Medical Academy

Vladikavkaz, Russia

O. Kotsoeva

North Ossetian State Medical Academy

Vladikavkaz, Russia

T. Bestaeva

Family Medicine Clinic

Vladikavkaz, Russia

Bibliografia

  1. Насонов Е.Л. (ред.). Российские клинические рекомендации. Ревматология. М., 2017. 464 с.
  2. Эрдес Ш., Фоломеева О.М. Проблема ревматических заболеваний в России. РМЖ. 2004;12(20):11212.
  3. Rapoport R., Kozin F., Mackel S., et al. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Am. J. Med. 1980;68(3):325-31. Doi: http://dx.doi.org/10.1016/0002-9343(80)90100-X.
  4. Scott D.G., Bacon PA. Systemic rheumatoid vasculitis: a clinical and laborathory study of 50 cases. Med. (Baltimore). 1981;60(4):288-97. Doi: http://dx.doi.org/10.1097/00005792-198107000-00004.
  5. Espinoza L.R., Espinoza C.G., Vasey F.B., Germain B.F. Oral methotrexate therapy for chronic rheumatoid arthritis ulcerations. J. Am Acad Dermatol. 1986;15(3):508-12. Doi: http://dx.doi. org/10.1016/S0190-9622(86)70202-8.
  6. Upchurch K.S., Heller K., Bress N.M. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J. Am Acad Dermatol. 1987;17(2 Pt. 2):355-59. doi: 10.1016/s0190-9622(87)70212-6.
  7. Simon G.A., Schmid P., Reifenrath W.G., et al. Wound healing after laser injury to skin - the effect of occlusion and vitamin Eur J. Pharm Sci. 1994;83(8):1101-106. Doi: http://dx.doi. org/10.1002/jps.2600830807.
  8. Combe B., Didry C., Gutierrez M., et al. Accelerated nodulosis and systemic manifestations during methotrexate therapy for rheumatoid arthritis. Eur J. Med. 1993;2(3):153-56.
  9. Chen K.R., Toyohara A., Suzuki A., Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J. Dermatol. 2002;147(5):905-13. Doi: http:// dx.doi.org/1 0. 1 046/j. 1365-2133.2002. 04933.x.
  10. Al Attar L., Shaver T. Abatacept as a Therapeutic Option for Rheumatoid Vasculitis. Cureus. 2018;10(4):e2506. doi: 10.7759/cureus.2506.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2019

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies